武汉三鹰生物技术有限公司与品牌介绍
武汉三鹰生物技术有限公司是美国Proteintech Group, Inc在中国的全资子公司,是一家以研发、生产、销售抗体/重组蛋白及相关产品为主要业务的生物技术公司,拥有严格的抗体生产、质检质控体系,产品涵盖整个生命科学领域。武汉三鹰生物技术有限公司作为全球最大的专业抗体生产商之一,凭借一支锐意进取的技术团队和稳定的技术平台,已研发和生产出14000多种特种抗体和14000多种人源蛋白产品。2018年4月新增Humankine高活性人源蛋白产品系列。目前,本公司已建立全球市场销售网络,美国、欧洲、中国和日本均有现货库存,全球24小时现货发售。
PROTEINTECH GROUP:
FOR SCIENTISTS, BY SCIENTISTS
As a company founded by scientists, Proteintech Group recognises the tireless efforts and sacrifices made by researchers to advance scientific discovery.
Proteintech aims to match its’ customers’ dedication to research by providing high quality, reliable reagents that contribute to reproducible results.
Find out exactly how Proteintech antibodies help our customers accelerate their research by watching this video.
ORIGINAL MANUFACTURER
ORIGINAL PRODUCTS
Part of Proteintech Group's early vision was to make all its own products, to the highest standards possible, thus assuming ultimate responsibility for their quality. In addition to its founders' refusal to source a single antibody from any other provider, they also refused to supply any other provider. This approach would offer researchers many advantages, including a way of avoiding the same antibodies sold under different brand names by different companies – an unregulated practice that still continues within the industry.
Ultimately, the 'Original Manufacturer' approach laid out by Proteintech's founders would contribute to an increasing sense of accountability in the antibody industry.
MISSION STATEMENT
One of its original founders and current
CEO Dr. Jason Li says of the reasons behind Proteintech's establishment:
"At the heart of our aspiration was a company for scientists by scientists; an antibody provider that would offer researchers the advantage — not investors."
Proteintech Milestones
2001
Proteintech is founded
August 2003
First publication with a pre-made antibody (Recoverin antibody – 10073-1-AP, Kicic et al. Journal of Neuroscience)
2004
Chinese office opens in Wuhan and 100th antibody is manufactured
April 2006
First monoclonal antibody goes on sale
2007
European office opens in Manchester and a Proteintech product features in a publication for the 50th time (Wang et al, Cell)
2008
Proteintech product features in a publication for the 100th time (Zhang et al, Blood)
2010
Proteintech features in a publication for the 1000th time (Nature Cell Biology)
March 3 2012
First ELISA kit goes on sale and European Office obtains ISO9001 certification
2013
New lab facilities are opened and a Proteintech product features in a publication for the 5,000th time
2014
Proteintech labs obtain SPF (specific pathogen free) grade Mouse house certification. Production ISO9001 and ISO13485 certification also obtained
January 2015
Launch of in-house RNAi validation department and a Proteintech product features in a publication for the 10,000th time
2018
Proteintech acquires Humanzyme, manufacturer of human-cell expressed proteins.
2019
Launch of 500+ antibodies directly conjugated with high-performance CoraLite®488, CoraLite®594 and CoraLite®647 dyes.
2020
Proteintech’s HumanKine® cytokines and growth factors now available in GMP-compliant versions for use in clinical trials and commercial manufacturing.
2020
Proteintech acquires ChromoTek, the market leader in nanobodies — high-performance recombinant reagents used for breakthrough research discoveries.
Present
Proteintech's growing catalog of antibodies against 13,000 targets is now available in 39 countries across 5 continents with over 120,000 citations.